These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19485802)

  • 21. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
    Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
    Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding transplant criteria for hepatocellular carcinoma: small steps down a long road.
    Sanchez W
    Hepatology; 2009 Mar; 49(3):724-5. PubMed ID: 19241486
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancing clinical outcomes in hepatocellular carcinoma.
    Abou-Alfa G
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S1. PubMed ID: 23457034
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of hepatocellular carcinoma after transplantation and human rights.
    Crippin JS
    Hepatology; 2007 Feb; 45(2):263-5. PubMed ID: 17256762
    [No Abstract]   [Full Text] [Related]  

  • 25. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
    Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
    Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?
    Volk M; Marrero JA
    Gastroenterology; 2008 May; 134(5):1612-4. PubMed ID: 18471530
    [No Abstract]   [Full Text] [Related]  

  • 27. c-myc overexpression in hepatocarcinogenesis.
    Feitelson MA
    Hum Pathol; 2004 Nov; 35(11):1299-302. PubMed ID: 15668885
    [No Abstract]   [Full Text] [Related]  

  • 28. Fibrolamellar hepatoma in Europe.
    Klompmaker IJ; Haagsma EB; Verwer R; Slooff MJ
    Am J Gastroenterol; 1991 Jun; 86(6):790-1. PubMed ID: 1645500
    [No Abstract]   [Full Text] [Related]  

  • 29. Granulomas in dysplastic nodules--an unusual morphological finding.
    Phelan S; Nolan N
    Histopathology; 2008 Jul; 53(1):114-5. PubMed ID: 18494782
    [No Abstract]   [Full Text] [Related]  

  • 30. [The value of treatment of liver transplantation for unresectable hepatocellular carcinoma].
    Zhang TL
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(18):1499-502. PubMed ID: 15500707
    [No Abstract]   [Full Text] [Related]  

  • 31. The new generation of hepatocellular markers.
    Mount S
    Cancer Cytopathol; 2012 Aug; 120(4):217-9. PubMed ID: 22760992
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
    J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of criteria for transplanting patients with hepatocellular carcinoma.
    Roayaie S; Schwartz ME
    Liver Transpl; 2008 Aug; 14(8):1071-2. PubMed ID: 18668660
    [No Abstract]   [Full Text] [Related]  

  • 34. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma.
    Jakubovic BD; Jothy S
    Exp Mol Pathol; 2007 Apr; 82(2):184-9. PubMed ID: 17258707
    [No Abstract]   [Full Text] [Related]  

  • 35. The quandary over liver transplantation for hepatocellular carcinoma: the greater sin?
    Fung J; Marsh W
    Liver Transpl; 2002 Sep; 8(9):775-7. PubMed ID: 12200776
    [No Abstract]   [Full Text] [Related]  

  • 36. Local ablation vs. resection for the treatment of hepatocellular carcinoma.
    Kao JH; Chen DS
    Hepatology; 2006 Feb; 43(2):373. PubMed ID: 16440360
    [No Abstract]   [Full Text] [Related]  

  • 37. Disparities in liver transplantation for localized hepatocellular carcinoma: race or socioeconomic class?
    Haque M; Zariat A
    Am J Gastroenterol; 2008 Jul; 103(7):1839-40; author reply 1840. PubMed ID: 18691200
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recognition of the indication of orthotopic liver transplantation for hepatocellular carcinoma in China].
    Chen GH; Lu MQ
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1441-3. PubMed ID: 17349163
    [No Abstract]   [Full Text] [Related]  

  • 39. Diabetes mellitus and prognosis after curative therapy for hepatocellular carcinoma: alas, still grave for those who are hyperglycemic.
    Teoh NC; Fan JG
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1633-4. PubMed ID: 19120856
    [No Abstract]   [Full Text] [Related]  

  • 40. Laparoscopic staging and radiofrequency of hepatocellular carcinoma in liver ci rrhosis. A "bridge" treatment to liver transplantation.
    Casaccia M; Andorno E; Nardi I; Santori G; Troilo B; Barabino G; Di Domenico S; Panaro F; Valente U
    Hepatogastroenterology; 2009; 56(91-92):793-7. PubMed ID: 19621704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.